Lumeris Integrates Schmitt-Thompson Triage Guidelines into Tom Platform

The partnership combines conversational AI with established medical decision support. By integrating Schmitt-Thompson’s evidence-based triage protocols, the Tom platform can now provide standardized, reliable guidance for patients reporting new symptoms or medication concerns. This transition shifts the platform from a general engagement tool to a clinically validated triage resource, allowing care teams to identify high-risk individuals more effectively.

Dr. David Carmouche, chief medical and commercial officer at Lumeris, noted that the collaboration allows the AI to act as an active extension of the care team. Rather than replacing physician oversight, the system generates structured summaries and prioritization recommendations after each interaction. This workflow allows healthcare organizations to maintain consistent clinical standards while extending support beyond traditional office hours. Schmitt-Thompson, which provides triage content to over 400 health systems, views the integration as a way to scale its gold-standard advice through modern, accessible technology.